Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Hydroxychloroquine-Induced Retinopathy in Systemic Lupus Erythematosus: Predictors of Progression Following Drug Discontinuation.
Journal: Research square
Published: September 03, 2026
Correlation of Hydroxychloroquine Whole Blood Levels With Real and Ideal Body Weight Dosing and Development of Retinal Toxicity.
Journal: Journal of vitreoretinal diseases
Published: August 08, 2026
Expert Consensus Statement on the Perioperative Management of Adult Patients Undergoing High-Risk Thyroidectomy from the Society for Head and Neck Anesthesia.
Journal: Anesthesia and analgesia
Published: June 10, 2026
"More guidelines than rules": reconsidering key gaps in the 2025 American College of Rheumatology treatment recommendations for systemic lupus erythematosus: comment on the article by Sammaritano et al.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 08, 2026
Association of Disease Activity and Socioeconomic Factors With Physical Activity in Patients With Systemic Lupus Erythematosus.
Journal: ACR open rheumatology
Published: March 25, 2026
Hemodynamic Effects of Prolonged Apneic Oxygenation in Laryngologic Surgery: A Randomized Controlled Pilot Trial.
Journal: World journal of otorhinolaryngology - head and neck surgery
Published: February 20, 2026
Impact of phosphodiesterase-5 inhibitor treatment delay on secondary Raynaud's phenomenon outcomes: A retrospective cohort study.
Journal: Journal of the American Academy of Dermatology
Published: January 15, 2026
Pharmacodynamic analysis of TYK2 inhibition by deucravacitinib: results from the phase 2 PAISLEY SLE trial in patients with active systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: December 04, 2025
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.
Journal: JCI insight
Published: November 25, 2025
Whole blood transcriptome profiling in patients treated with deucravacitinib and novel mechanistic insights into TYK2 inhibition in lupus: results from a post hoc analysis of the PAISLEY SLE phase 2 trial.
Journal: Annals of the rheumatic diseases
Published: September 23, 2025
A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases.
Journal: ACR open rheumatology
Published: July 22, 2025
Last Updated: 09/26/2026